Firmagon, the newly FDA approved gonadotropin-releasing hormone (GnRH) receptor blocker should perhaps be considered as a better alternative to the traditionally used ADT drugs like lupron and zoladex (GnRH agonists) which are the current standard of care. Recent data released from the ongoing five-year Firmagon (degarelix) extension study (CS21a) has demonstrated the long term efficacy [...]
Bisphosphonates, specifically Zometa, is commonly used in the treatment of men with advanced prostate cancer. Zometa is used to treat and protect bones from developing fractures. Bisphosphonates are potent inhibitors of bone resorption. Additionally, in vitro studies show that zolendronic acid also inhibits prostate cancer cell growth by activating apoptosis (A form of cell death [...]
For some reason Charlie Sheen thinks he is winning. It's one of his catch phrases after all. Sure he's rich and famous but he's also fired, and kind of a jerk. Sadly he's in denial about his seriously deep issues. In my book he's losing. He's losing big. He's a dad and he needs to [...]
Stroke is an all too common disabling event and killer. As we age and as we go through the various treatments to fight our advanced prostate cancer our risks for a stroke only increase. Neurologists claim that if we can get care to a stroke victim within 3 hours of its onset it’s possible to [...]
As we all anxiously wait for the FDA to finally make a determination about the pending application for approval of the investigational androgen biosynthesis inhibitor abiraterone acetate more data rolls in showing that supports the need to have a speedy approval. A new study published March 1, 2011, out of Italy adds support to the [...]